Metformin

Metformin is a widely prescribed medication for type 2 diabetes that also shows promise in other areas like weight management and aging. Studies have elucidated its mechanisms, revealing that metformin primarily works by reducing glucose production in the liver and improving insulin sensitivity in muscle and fat tissues. It has been shown to activate AMP-activated protein kinase (AMPK), a key regulator of cellular energy homeostasis, which can lead to reduced inflammation and improved metabolic function. In animal studies, metformin has demonstrated potential anti-aging effects by decelerating the aging process in male monkeys, suggesting it may have broader health benefits beyond diabetes management. Metformin's impact on weight loss is also well-documented, particularly in individuals with obesity, where it can help reduce body weight and improve metabolic markers.

Metformin connects to pathways involving glucose metabolism, insulin signaling, and cellular energy regulation. It also links to research on aging and longevity, as well as studies exploring its potential therapeutic uses beyond diabetes, such as in cancer prevention. While the evidence for metformin's effects is robust, more clinical trials are needed to fully understand its long-term benefits and risks in diverse populations.

Sources

• Cellular and Molecular Mechanisms of Metformin Action. (PMID:32897388)
• Metformin decelerates aging clock in male monkeys. (PMID:39270656)
• Metformin: Mechanisms in Human Obesity and Weight Loss. (PMID:30874963)
• Metformin--mode of action and clinical implications for diabetes and cancer. (PMID:24393785)
• Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes. (PMID:37397787)
• Metformin: from mechanisms of action to therapies. (PMID:25456737)

_Worker-drafted node, Hermes writer enrichment, pending editorial review._